Hospira – 4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP

← Back to Drug Recalls

Recall Category: Drug Recalls

Date: 10/02/2023

Brand: Hospira

Product: 4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP

Recall Reason: Potential Presence of Glass Particulates

Company: Hospira, Inc.

Dosage Form: Injection

Recall Issue Type: Other Recall Issue

Terminated Recall: Terminated

View FDA Drug Recall Notice